Clinical Trials
27 trialsNCT05689112 2024-08-21
Microscopy Imaging of Whole-mount Stained Human Tissues
National Taiwan University Hospital
Unknown
NCT06152822 2023-12-01
Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases
Tongji Hospital
Phase 2 Unknown
NCT05144867 2023-10-17
SRSvsWBRT
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3 Unknown
NCT03613181 2023-04-24
ANGLeD
Angiochem Inc
Phase 3 Unknown
NCT05170087 2023-04-19
Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies
Sunnybrook Health Sciences Centre
Unknown
NCT04582968 2023-01-18
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
Fudan University
Phase 1/2 Unknown
NCT05018702 2022-06-01
ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases
Fudan University
Phase 2 Unknown
NCT04334330 2022-05-02
Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China
Sun Yat-sen University
Phase 2 Unknown
NCT02185352 2021-05-07
A-Plus
National Taiwan University Hospital
Phase 2 Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT03617341 2020-10-27
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer
Yonsei University
Unknown
NCT04001725 2019-11-13
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT04061408 2019-08-19
FSRT in Breast Cancer Patients With Brain Metastases
Fudan University
Phase 2 Unknown
NCT03933982 2019-05-29
Pyrotinib
ChineseAMS
Phase 2 Unknown
NCT01782274 2017-10-12
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer
NeuroVita Clinic
Phase 2/3 Unknown
NCT02448576 2017-06-01
PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy
Sun Yat-sen University
Phase NA Unknown
NCT03002532 2016-12-23
Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer
Affiliated Hospital to Academy of Military Medical Sciences
Phase NA Unknown
NCT02457650 2016-08-03
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Shenzhen Second People's Hospital
Phase 1 Unknown
NCT00122239 2016-03-16
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
AHS Cancer Control Alberta
Unknown
NCT01801852 2016-01-28
Autologous Natural Killer T Cells Infusion for the Treatment of Cancer
Chinese PLA General Hospital
Phase NA Unknown
NCT02327442 2014-12-30
GNNGB
Xijing Hospital
Unknown
NCT00769613 2013-12-18
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00398437 2013-08-12
Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00637637 2013-08-12
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01641003 2012-07-16
Isolation and Characterization of Cancer Stem Cells Using iFP Technique
Rambam Health Care Campus
Unknown
NCT00938756 2010-04-07
Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome
National Cancer Institute (NCI)
Phase NA Unknown
NCT00875355 2009-08-26
Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown